annual EBITDA:
-$263.94M-$81.34M(-44.55%)Summary
- As of today (September 12, 2025), RYTM annual EBITDA is -$263.94 million, with the most recent change of -$81.34 million (-44.55%) on December 31, 2024.
- During the last 3 years, RYTM annual EBITDA has fallen by -$95.04 million (-56.27%).
- RYTM annual EBITDA is now -3964.99% below its all-time high of -$6.49 million, reached on December 1, 2014.
Performance
RYTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$44.92M+$1.70M(+3.66%)Summary
- As of today (September 12, 2025), RYTM quarterly EBITDA is -$44.92 million, with the most recent change of +$1.70 million (+3.66%) on June 30, 2025.
- Over the past year, RYTM quarterly EBITDA has dropped by -$4.83 million (-12.05%).
- RYTM quarterly EBITDA is now -14530.94% below its all-time high of -$307.00 thousand, reached on September 1, 2014.
Performance
RYTM quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$175.91M-$4.83M(-2.82%)Summary
- As of today (September 12, 2025), RYTM TTM EBITDA is -$175.91 million, with the most recent change of -$4.83 million (-2.82%) on June 30, 2025.
- Over the past year, RYTM TTM EBITDA has increased by +$87.92 million (+33.32%).
- RYTM TTM EBITDA is now -4431.43% below its all-time high of -$3.88 million, reached on September 1, 2015.
Performance
RYTM TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
RYTM EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -44.5% | -12.1% | +33.3% |
| 3 y3 years | -56.3% | -0.4% | +8.3% |
| 5 y5 years | -81.8% | -41.5% | -27.6% |
RYTM EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -56.3% | at low | -15.5% | +67.8% | -2.8% | +34.8% |
| 5 y | 5-year | -94.2% | at low | -41.5% | +67.8% | -30.4% | +34.8% |
| alltime | all time | -3965.0% | at low | <-9999.0% | +67.8% | -4431.4% | +34.8% |
RYTM EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$44.92M(-3.7%) | -$175.91M(+2.8%) |
| Mar 2025 | - | -$46.62M(+14.1%) | -$171.08M(-35.2%) |
| Dec 2024 | -$263.94M(+44.5%) | -$40.87M(-6.0%) | -$263.94M(+0.0%) |
| Sep 2024 | - | -$43.50M(+8.5%) | -$263.92M(+0.0%) |
| Jun 2024 | - | -$40.09M(-71.3%) | -$263.83M(-2.2%) |
| Mar 2024 | - | -$139.48M(+241.5%) | -$269.80M(+48.0%) |
| Dec 2023 | -$182.60M(+2.7%) | -$40.85M(-5.9%) | -$182.30M(-0.5%) |
| Sep 2023 | - | -$43.41M(-5.8%) | -$183.18M(+2.5%) |
| Jun 2023 | - | -$46.06M(-11.4%) | -$178.67M(+0.8%) |
| Mar 2023 | - | -$51.98M(+24.6%) | -$177.33M(-0.2%) |
| Dec 2022 | -$177.75M(+5.2%) | -$41.73M(+7.3%) | -$177.75M(-4.8%) |
| Sep 2022 | - | -$38.89M(-13.0%) | -$186.69M(-2.6%) |
| Jun 2022 | - | -$44.72M(-14.7%) | -$191.72M(+2.5%) |
| Mar 2022 | - | -$52.41M(+3.4%) | -$187.11M(+10.8%) |
| Dec 2021 | -$168.90M(+24.3%) | -$50.66M(+15.3%) | -$168.90M(+10.3%) |
| Sep 2021 | - | -$43.92M(+9.5%) | -$153.13M(+6.8%) |
| Jun 2021 | - | -$40.12M(+17.3%) | -$143.32M(+6.2%) |
| Mar 2021 | - | -$34.20M(-2.0%) | -$134.95M(-0.7%) |
| Dec 2020 | -$135.88M(-6.4%) | -$34.90M(+2.3%) | -$135.88M(+0.6%) |
| Sep 2020 | - | -$34.11M(+7.5%) | -$135.02M(-2.0%) |
| Jun 2020 | - | -$31.75M(-9.6%) | -$137.83M(-8.1%) |
| Mar 2020 | - | -$35.13M(+3.2%) | -$150.02M(+3.3%) |
| Dec 2019 | -$145.17M | -$34.03M(-7.8%) | -$145.17M(+5.1%) |
| Sep 2019 | - | -$36.92M(-16.0%) | -$138.07M(+14.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$43.94M(+45.1%) | -$120.29M(+31.7%) |
| Mar 2019 | - | -$30.27M(+12.4%) | -$91.31M(+17.1%) |
| Dec 2018 | -$77.97M(+142.2%) | -$26.94M(+40.8%) | -$77.97M(+25.8%) |
| Sep 2018 | - | -$19.14M(+27.9%) | -$61.96M(+21.4%) |
| Jun 2018 | - | -$14.96M(-11.7%) | -$51.05M(+19.3%) |
| Mar 2018 | - | -$16.94M(+55.1%) | -$42.79M(+32.9%) |
| Dec 2017 | -$32.19M(+25.0%) | -$10.92M(+32.7%) | -$32.19M(+51.4%) |
| Sep 2017 | - | -$8.23M(+22.9%) | -$21.27M(+63.1%) |
| Jun 2017 | - | -$6.70M(+5.8%) | -$13.04M(+8.3%) |
| Mar 2017 | - | -$6.33M(+11.0%) | -$12.04M(-39.4%) |
| Dec 2016 | -$25.76M(+143.6%) | - | - |
| Jun 2016 | - | -$5.71M(+5.8%) | -$19.86M(+40.3%) |
| Mar 2016 | - | -$5.39M(-4.5%) | -$14.15M(+61.5%) |
| Dec 2015 | -$10.57M(+62.8%) | - | - |
| Dec 2015 | - | -$5.64M(+80.9%) | -$8.76M(+125.7%) |
| Sep 2015 | - | -$3.12M(+309.4%) | -$3.88M(-51.7%) |
| Dec 2014 | -$6.49M(-69.7%) | -$762.00K(+148.2%) | -$8.03M(+10.5%) |
| Sep 2014 | - | -$307.00K(-91.1%) | -$7.27M(+4.4%) |
| Jun 2014 | - | -$3.43M(-2.8%) | -$6.96M(-29.5%) |
| Mar 2014 | - | -$3.53M(-44.4%) | -$9.88M(-8.7%) |
| Dec 2013 | -$21.43M(+18.2%) | - | - |
| Jun 2013 | - | -$6.35M(+41.7%) | -$10.82M(+141.7%) |
| Mar 2013 | - | -$4.48M | -$4.48M |
| Dec 2012 | -$18.12M | - | - |
FAQ
- What is Rhythm Pharmaceuticals, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Rhythm Pharmaceuticals, Inc.?
- What is Rhythm Pharmaceuticals, Inc. annual EBITDA year-on-year change?
- What is Rhythm Pharmaceuticals, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Rhythm Pharmaceuticals, Inc.?
- What is Rhythm Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
- What is Rhythm Pharmaceuticals, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Rhythm Pharmaceuticals, Inc.?
- What is Rhythm Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
What is Rhythm Pharmaceuticals, Inc. annual EBITDA?
The current annual EBITDA of RYTM is -$263.94M
What is the all time high annual EBITDA for Rhythm Pharmaceuticals, Inc.?
Rhythm Pharmaceuticals, Inc. all-time high annual EBITDA is -$6.49M
What is Rhythm Pharmaceuticals, Inc. annual EBITDA year-on-year change?
Over the past year, RYTM annual EBITDA has changed by -$81.34M (-44.55%)
What is Rhythm Pharmaceuticals, Inc. quarterly EBITDA?
The current quarterly EBITDA of RYTM is -$44.92M
What is the all time high quarterly EBITDA for Rhythm Pharmaceuticals, Inc.?
Rhythm Pharmaceuticals, Inc. all-time high quarterly EBITDA is -$307.00K
What is Rhythm Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
Over the past year, RYTM quarterly EBITDA has changed by -$4.83M (-12.05%)
What is Rhythm Pharmaceuticals, Inc. TTM EBITDA?
The current TTM EBITDA of RYTM is -$175.91M
What is the all time high TTM EBITDA for Rhythm Pharmaceuticals, Inc.?
Rhythm Pharmaceuticals, Inc. all-time high TTM EBITDA is -$3.88M
What is Rhythm Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
Over the past year, RYTM TTM EBITDA has changed by +$87.92M (+33.32%)